These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Some empirical notes on the epo epidemic in professional cycling. Lodewijkx HF; Brouwer B Res Q Exerc Sport; 2011 Dec; 82(4):740-54. PubMed ID: 22276416 [TBL] [Abstract][Full Text] [Related]
4. Little soldiers in their cardboard cells. van Breda E; Benders J; Kuipers H Br J Clin Pharmacol; 2014 Mar; 77(3):580-1. PubMed ID: 23772979 [No Abstract] [Full Text] [Related]
5. What is a normal red-blood cell mass for professional cyclists? Saris WH; Senden JM; Brouns F Lancet; 1998 Nov; 352(9142):1758. PubMed ID: 9848362 [No Abstract] [Full Text] [Related]
6. Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk-benefit. Heuberger JA; Cohen Tervaert JM; Schepers FM; Vliegenthart AD; Rotmans JI; Daniels JM; Burggraaf J; Cohen AF Br J Clin Pharmacol; 2013 Jun; 75(6):1406-21. PubMed ID: 23216370 [TBL] [Abstract][Full Text] [Related]
7. The effect of a caffeinated mouth-rinse on endurance cycling time-trial performance. Doering TM; Fell JW; Leveritt MD; Desbrow B; Shing CM Int J Sport Nutr Exerc Metab; 2014 Feb; 24(1):90-7. PubMed ID: 23980239 [TBL] [Abstract][Full Text] [Related]
8. Peddling drugs to the pedal pushers. Lancet; 1998 Aug; 352(9126):415. PubMed ID: 9708742 [No Abstract] [Full Text] [Related]
9. Enhancement of exercise performance with inhaled albuterol. Bedi JF; Gong H; Horvath SM Can J Sport Sci; 1988 Jun; 13(2):144-8. PubMed ID: 3293733 [TBL] [Abstract][Full Text] [Related]
10. American College of Sports Medicine position stand. The use of blood doping as an ergogenic aid. Sawka MN; Joyner MJ; Miles DS; Robertson RJ; Spriet LL; Young AJ Med Sci Sports Exerc; 1996 Jun; 28(6):i-viii. PubMed ID: 8926864 [TBL] [Abstract][Full Text] [Related]
11. Effect of beta-hydroxy beta-methylbutyrate on the onset of blood lactate accumulation and V(O)(2) peak in endurance-trained cyclists. Vukovich MD; Dreifort GD J Strength Cond Res; 2001 Nov; 15(4):491-7. PubMed ID: 11726262 [TBL] [Abstract][Full Text] [Related]
12. The influence of body mass in endurance bicycling. Swain DP Med Sci Sports Exerc; 1994 Jan; 26(1):58-63. PubMed ID: 8133740 [TBL] [Abstract][Full Text] [Related]
13. Glucocorticoids: a doping agent? Duclos M Endocrinol Metab Clin North Am; 2010 Mar; 39(1):107-26, ix-x. PubMed ID: 20122453 [TBL] [Abstract][Full Text] [Related]
15. Caffeine lowers perceptual response and increases power output during high-intensity cycling. Doherty M; Smith P; Hughes M; Davison R J Sports Sci; 2004 Jul; 22(7):637-43. PubMed ID: 15370494 [TBL] [Abstract][Full Text] [Related]
16. The effects of different doses of caffeine on endurance cycling time trial performance. Desbrow B; Biddulph C; Devlin B; Grant GD; Anoopkumar-Dukie S; Leveritt MD J Sports Sci; 2012; 30(2):115-20. PubMed ID: 22142020 [TBL] [Abstract][Full Text] [Related]
17. [Pharma-clinics. Doping with erythropoietin or the misuse of therapeutic advances]. Scheen AJ Rev Med Liege; 1998 Aug; 53(8):499-502. PubMed ID: 9810213 [TBL] [Abstract][Full Text] [Related]
20. Condemning and condoning: Elite amateur cyclists' perspectives on drug use and professional cycling. Outram SM; Stewart B Int J Drug Policy; 2015 Jul; 26(7):682-7. PubMed ID: 25666447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]